CBD+13
Brand: T-Relief
Dr. Feb's Analysis
Scientific Mechanism
T-Relief CBD+13 utilizes a dual-action approach. Cannabidiol (15 mg) interacts with the body's endocannabinoid system (ECS), specifically binding to CB2 receptors found on immune and peripheral nerve cells. This interaction helps modulate cytokine release and reduce localized inflammation. The Proprietary Blend (104 mg), featuring botanicals like arnica and calendula, works synergistically. Arnica contains helenalin, which inhibits NF-kB (a protein complex that controls DNA transcription), while calendula promotes cellular repair. MCT Oil powder enhances the bioavailability of these fat-soluble compounds, ensuring maximum absorption for rapid onset.
Key Benefits
Key benefits include:
- Reduction in acute and chronic pain signals
- Decreased inflammation at the cellular level
- Improved joint mobility and flexibility
- Non-habit forming alternative to opioids
- Enhanced recovery from physical exertion
Usage & Safety
The standard dosage is 1 tablet per serving. For optimal results, allow the tablet to dissolve sublingually (under the tongue) for 30-60 seconds before swallowing to bypass first-pass metabolism. Do not exceed the recommended dose. Consult a physician if taking blood-thinning medications, as CBD can inhibit CYP450 enzymes. Not for use by those under 18, pregnant, or nursing.